CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- 8-K Event Results of operations · Other events
- 4 Open-market sale Director sold 850 shares at $1.46 ($1,237)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement · Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 75,000 shares at $2.00 ($150,000)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $2.00 ($50,000)
- 4 Open-market buy Director bought 125,000 shares at $2.00 ($250,000)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $2.00 ($5,000)
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
Page 3 of 21 · 406 filings